
Opinion|Videos|August 2, 2024
High-Risk Populations for Severe Pneumococcal Infection
Key opinion leaders identify high-risk populations for invasive pneumococcal disease, explain the underlying factors contributing to their increased susceptibility, and offer strategies to improve suboptimal vaccination rates, particularly among historically underserved communities.
Advertisement
Episodes in this series

- Who are the high-risk
populations for developing invasive pneumococcal disease?- What is the rationale for why certain populations are at risk for severe pneumococcal infections?
- How can we improve inadequate pneumococcal vaccine uptake rates, specifically in historically marginalized groups?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Early Oral Antiviral Use Associated With Lower Risk of Post–COVID-19 Condition, Study Finds
2
Retatrutide Delivers Bariatric-Level Weight Loss in Pivotal Phase 3 TRIUMPH-1 Trial
3
Oral GLP-1 Orforglipron Is Approved for Obesity
4
From GLP-1s to Vaccines, APhA 2026 Showcased the Modern Clinical Pharmacist
5




































































































































